Theriva Biologics, Inc. (TOVX) Tops Q3 EPS by 7c

Theriva Biologics, Inc. (NYSE: TOVX) reported Q3 EPS of ($0.33), $0.07 better than the analyst estimate of ($0.40).

For earnings history and earnings-related data on Theriva Biologics, Inc. (TOVX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c